4//SEC Filing
Altchem Ltd 4
Accession 0001752864-23-000002
CIK 0001739426other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 1:06 PM ET
Size
10.3 KB
Accession
0001752864-23-000002
Insider Transaction Report
Form 4
Altchem Ltd
10% Owner
Transactions
- Sale
Ordinary Shares
2023-10-19$0.05/sh−9,363,760$431,669→ 9,700,000 total - Sale
Ordinary Shares
2023-10-20$0.03/sh−4,758,899$148,478→ 4,941,101 total
Holdings
- 1,182,243(indirect: By LLC)
Ordinary Shares
Orbit Co-Invest A-1 LLC
10% Owner
Transactions
- Sale
Ordinary Shares
2023-10-19$0.05/sh−9,363,760$431,669→ 9,700,000 total - Sale
Ordinary Shares
2023-10-20$0.03/sh−4,758,899$148,478→ 4,941,101 total
Holdings
- 1,182,243(indirect: By LLC)
Ordinary Shares
Footnotes (3)
- [F1]The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0400 to $0.0580, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0300 to $0.0373, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents shares of the Issuer held by Orbit Co-Invest A-1 LLC. Altchem Limited is the sole manager of Orbit Co-Invest A-1 LLC. As a result, Altchem Limited may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest A-1 LLC. Altchem Limited disclaims beneficial ownership of such shares and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Documents
Issuer
RVL Pharmaceuticals plc
CIK 0001739426
Entity typeother
IncorporatedCyprus
Related Parties
1- filerCIK 0001752864
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 1:06 PM ET
- Size
- 10.3 KB